In the realm of obesity treatment, two medications have emerged as promising options: tirzepatide and Semaglutide GLP-1
Preferred in bodybuilding communities for theoretical local growth enhancement, though site-specific effects are debated
Coverage at NY Times, front page today and my input to that piece Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
Studies have shown that having a higher level of glutathione in the body can help reduce the damaging effects of oxidative stress, which is a major contributor to aging and related illnesses
Reported public examples tied to reduced-price initiatives suggest injectable reduced-tier discussions around the low-to-mid hundreds per month and starter oral tiers around $149/month, but actual costs depend on eligibility, supply, and pharmacy choices